Biomedical engineers have used a CRISPR/Cas9 genetic engineering technique to turn off a gene that regulates cholesterol levels in adult mice, leading to reduced blood cholesterol levels and gene repression lasting for six months after a single treatment. This marks the first time researchers have delivered CRISPR/Cas9 repressors for targeted therapeutic gene silencing in adult animal models.
from Top Health News – ScienceDaily http://bit.ly/2HV66Qh
from Tumblr http://bit.ly/2r6o3Rh
No comments:
Post a Comment